Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001112278-14-000002
Filing Date
2014-04-10
Accepted
2014-04-10 15:16:16
Documents
1
Period of Report
2014-04-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 7004
  Complete submission text file 0001112278-14-000002.txt   8464
Mailing Address
Business Address 222 N. LASALLE STREET, SUITE 2000 CHICAGO IL 60601
CVF LLC (Reporting) CIK: 0001112278 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 14756835

Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations